Latest News about MMJ BioPharma Cultivation
Recent news which mentions MMJ BioPharma Cultivation
EXCLUSIVE: DEA Stalling Hinders Critical Clinical Trials For Debilitating Conditions, Says MMJ BioPharma CEO
September 12, 2024
Tickers
DEA
From Benzinga
MMJ's THC-CBD Drug Ready For MS And Huntington's Disease Clinical Trials, Awaiting DEA And FDA Final Approvals
December 16, 2022
From Benzinga
MMJ BioPharma Cultivation Receives Marijuana Grow Equipment Creating Marijuana Center Of Excellence
July 08, 2022
From Benzinga
'DEA Has Blown It Again' - MMJ Request Federal Court Action For Emergency Motion To Expedite
May 05, 2022
From Benzinga
MMJ BioPharma Cultivation To Produce Quality Cannabis, Meeting DEA's Definition Of Chemical Reproducibility
April 26, 2022
Tickers
DEA
From Benzinga